Related Experiment Videos
Alternative pathways for the activation of factor XIII
British Journal of Haematology
|August 1, 1975
Summary
Plasma Factor XIII (FXIII) activation was studied using various proteases. Factor Xa, like thrombin, activates FXIII, suggesting an alternative pathway for blood clot formation and thrombus development.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Factor XIII (FXIII) is a plasma proenzyme crucial for fibrin stabilization.
- FXIII activation catalyzes the formation of epsilon(gamma-glutamyl)lysyl bonds in fibrin, crosslinking the clot.
- Understanding FXIII activation pathways is vital for comprehending blood coagulation and thrombosis.
Purpose of the Study:
- To quantitatively assess the activation of purified plasma Factor XIII by various serine proteases.
- To investigate the role of calcium in Factor XIII activation by different enzymes.
- To explore potential alternative pathways for Factor XIII activation in vivo.
Main Methods:
- Purified plasma Factor XIII was activated using thrombin, trypsin, chymotrypsin, factor Xa, and Reptilase.
- The fluorescent amine incorporation assay was employed for quantitative activation analysis.
- Polyacrylamide gel electrophoresis was used to examine activation products.
Main Results:
- Highly purified thrombin and trypsin effectively activated Factor XIII, independent of calcium.
- Factor Xa also activated Factor XIII, but this process was calcium-dependent.
- Chymotrypsin did not exhibit transglutaminase activity on Factor XIII.
- Reptilase activity was attributed to contaminating enzymes in less purified preparations.
Conclusions:
- Factor Xa can activate Factor XIII, potentially forming Factor XIIIa via an alternative pathway in vivo.
- Factor XIIIa formation by Factor Xa could contribute to alternative thrombus formation pathways.
- Dual activation of Factor XIII by thrombin and Factor Xa offers additional regulatory control points in blood coagulation.